3/13/2012 Update Antibiotics-เวชศาสตร ครอบคร ว. First. Cefazolin. Cephalexin Cefadroxil. Cefaclor. 3/13/2012 Update Antibiotics-เวชศาสตร ครอบคร ว

Size: px
Start display at page:

Download "3/13/2012 Update Antibiotics-เวชศาสตร ครอบคร ว. First. Cefazolin. Cephalexin Cefadroxil. Cefaclor. 3/13/2012 Update Antibiotics-เวชศาสตร ครอบคร ว"

Transcription

1 Therapeutic eview of Cephalosporins ole of Cephalosporins in Multi Drug esistance(md) Era. Panpit Suwangool Chulalongkorn University Problem of Bacterial esistance in Thailand 1.Multi-drug-resistant GNB (MD-GNB) [ esist > classes antibiotics ] - Acinetobacter sp. - Pseudomonas aeruginosa - Klebsiella,E.coli. Enterobacter.MD-GPB -MSA(methicillin resistant S.aureus) -DSP( drug resist S.pneumoniae ) /1/1 Update Antibiotics-เวชศาสตร 1 /1/1 Update Antibiotics-เวชศาสตร MD-Gm-Neg Infections 1. Nosocomial Infections. Infection In Cancer Patient. Septic Patient with ecent-/frequent antibiotic Use /1/1 Update Antibiotics-เวชศาสตร First Cephalosporins : 5. Generations Cefazolin Cephalexin Cefadroxil Cefaclor Second Cefuroxime Cefamandole Cefoxitin Third Cefotaxime Ceftriaxone Ceftazidime Cefoperazone Cefixime Ceftibuten Cefdinir Cefditoren Cefpodoxime /1/1 Update Antibiotics-เวชศาสตร Fourth Cefpirome Cefepime Fifth Gen ceftobiprole ceftaroline Vitro-activity of parenteral cephalosporins Cephalosporin generation First Second Third Fourth Fifth /1/1 Update Antibiotics-เวชศาสตร Bacterial activity Gram positive Gram negative & MSA Antibacterial activity of parenteral cephalosporins Cephalosporins Cefazolin Cefuroxime Cefamandole Cefoxitin Cefotaxime Ceftriaxone Ceftazidime Cefpirome Gram positive Strep Stap Cefepime /1/1 Update Antibiotics-เวชศาสตร Gram negative Enterobacteriaceae P. aeug

2 6 year old female, HT, DM, admitted because of fever, diagnosed acute pyelonephritis. She was given Antibiotic IV., Day rd. Better.. Urine and blood culture grew E.coli, How long to give antibiotic?? Parenteral days Oral?? 7 8 IDSA Uncomplicated UTI Treatment Guidelines She became afebrile on day th What is your plan for antibiotic? 1. Duration of antibiotic?. Should IV ceftriaxone be continued?.1 yes?. No : what agent should be switched to? ecommendation Acute uncomplicated cystitis Single-dose therapy is generally less effective than the same antimicrobial used for longer durations Most antimicrobials given for -5 days are as effective as the same antimicrobial given for a longer duration TMP-SMX for d should be considered the current standard therapy TMP alone is equivalent to TMP-SMX Ofloxacin is equivalent to TMP-SMX Other fluoroquinolones, such as, ciprofloxacin, and fleroxacin are probably of similar effectiveness Nitrofurantoin and fosfomycin may become more useful as resistance to TMP-SMX and TMP increase Fluoroquinolones are not recommended as initial empirical therapy except in communities with high rates of resistance (ie, >1%-%) to TMP-SMX or TMP among uropathogens Category or grade of recommendation A, I A, I A, I A, II A, I A, II B, I Not rated 9 1 Clin Infect Dis 11 IDSA Uncomplicated UTI Treatment Guidelines ecommendation Acute uncomplicated pyelonephritis 1 d of antimicrobial therapy is appropriate Courses of highly active agents as short as 7 d may e sufficient for mild or moderate cases Mild cases can be managed with oral medications An oral fluoroquinolone is recommended or If the organism is known to be susceptible, TMP-SMX Patients with more severe cases of acute pyelonephriits should be shospitalized and treated with a parenteral fluoroquinolone, an aminoglycoside+ ampicillin, or an extended-spectrum cephalosporin+an aminoglycoside or With improvement, can change to an oral antimicrobial to which the organsims is susceptible to complete the couse of therapy Category or grade of recommendation A, I B, I A, II A, II B, II A, II B, III B, II 11 Bacterial etiology of urinary tract infection Gram-negative E.coli P mirabilis Klebsiella sp Citrobacter sp Enterobacter sp P aeruginosa Other Gram-positive Coagulase-negative staphylococci Enterococci Group B streptococci S. aureus Other % Uncomplicated b 1- a Data from Nicolle LE. A practical guide to the management of complicated urinary Tract infection. Drugs 1997; b S saprophyticus %Complicated a

3 Management of Urinary Tract Infections Acute Uncomplicated Cystitis Women yrs, non pregnant Urinalysis Evidence - based Clinical Practice Guideline To promote best practice linked to OUTCOME and COST EFFECTIVENESS 1 1st UTI No recent antibiotic * Ciproflox, Ofloxacin,Levoflox x days FU-Urinalysis * NO UINE CULTUE ecurrent UTI, Previous UTI due to pathogen ecent Antibiotic + Urine culture then Ciprofloxacin, Ofloxacin or Levoflox or rd cephalosporins 1 Why - No Urine Culture in Cystitis?? Are Majority of Uropathogen in Cystitis susceptible? LUTI in non Pregnant Women age yrs can be treated with antibiotic without any testing Identifying Barriers and Tailoring Intervention to improve the management of UTI : a pragmatic study using qualitative methods BMC Health Service esearch ; BMJ ;5:67 15 *No need for Urine culture in 1st episode acute uncomplicated cystitis in women 16 Why not TMP-SMX (Co-trimoxazole) (gold standard antibiotic in many countries) Uropathogen in Thailand TMP-SMX esistance >% (Many Guideline, US, EU. If, esistance > 1 - % not appropriate) Why?? Aim / Objective of LUTI Management 1) Prompt relieve of Symptoms ) Cure as LUTI So is Norfloxacin appropriate as 1st line empiric in 1st episode Cystitis 17 18

4 Impact of esistance on the treatment of UTI PK : High Urine Concentration esistant Uropathogen - < 5 % Cure Susceptible Uropathogen > 9% Cure Acute Pyelonephritis : Moderate to Severe High fever, severe flank pain CVA tenderness Systemic S/S Sepsis Nausea - vomiting Hospitalization UA - Urine C/S Blood Culture Clin Therapeutic ;:88 Urology 1997; Parenteal 8-7 hr. (ต อ) Improving Parenteral Ceftriaxone 1- g Once daily 8-7 hr. Oral Switch (IB) Ciprofloxacin Ofloxacin,Levofloxacin 1-1 days (Total antibiotic days) Not improve pathogen Change antibiotic S pathogen Investigation 1 Uropathogen in Community-acquired UTI in Thailand: Increasing nd generation Quinolone - esistant - E.coli (esistant to Oflox / Ciproflox) More common in UUIT than LUTI Severity of UUTI > LUTI What is antibiotic of choice in case with resistance 1 : rd or advanced generation cephalosporins : rd and th generation Quinolones ESBL producing Bacteria (extended spectrum beta lactamase) Found in complicated UTIs,healthcare asso-infections Klebsiella spp esp K. pneumoniae E. coli Therefore do not test ESBL in others Bacteria When to suspect ESBL producing Klebsiella & E.coli Ceftazidime-resistant Klebsiella or E.coli esp with co-resistant to gentamicin/amikacin may be resistant to Fluoroquinolone Problems of ESBL even in Klebsiella or E. coli Clinical dilemma Frequently resistant to many agents Mostly treated with carbapenems..resulted in more MD-GNB /1/1 Update Antibiotics-เวชศาสตร Chen & Livemore 199, Sirot 1995, Sazbo 1,Paterson 8 /1/1 Update Antibiotics-เวชศาสตร

5 Problems posed by ESBLs Treatment options for infections Caused by ESBL-producing organism Clinical dilemma Serious infections Carbapenem always recommended Combination of β-lactam/β-lactamase Carbapenems,Tigecycline UTI,not serious/severe β-lactam/β-lactamase inhibitor inhibitors may be useful Cefoperazone/sulbactam,pip/tazobactam ( cefoperazone-sulbactam ) th Cephalosporin+Aminglycoside Sazbo 1,Paterson 8 /1/1 Update Antibiotics-เวชศาสตร 5 /1/1 Update Antibiotics-เวชศาสตร 6 Implication for Antimicrobial Dosing α PK/PD Principles Bacterial-killing activities of antibiotics : B-lactams Carbapenems T > MIC (% of dosing interval) MIC MIC Normal, mild-moderate Severe infections Neutropenic host P.aeruginosa infections -6 > Hr. /1/1 Update Antibiotics-เวชศาสตร 7 Turnidge J:CID 1998, McNabb BL: Pharmacokynamics /1/1 Update Antibiotics-เวชศาสตร 8 Advantage of cephalosporins? 1. Broad spectrum. Stability to β-lactamase. Oral and parenteral preparations. High safety profile similar to amoxicillin 5. easonable costs 9 Cost Of Treatment Direct Cost Drug Cost Drug Administration - Monitoring Indirect Cost Hospitalization Investigation. etc. Intangible Cost Time - Income Cost Family Visit evisit /1/1 etc Update Antibiotics-เวชศาสตร 5

6 Good oral antibiotics Why Oral Beta-lactams? 1. Optimal PK-PD properties (excellent oral absorption, good penetration to infection sites, When amoxicillin? long terminal disposition half-life, and stability in serum) When Amoxici-clavulanate?. Low adverse effect. Convenience (OD or BID dosing) When Cephalosporins? 1 Classification Of Oral Cephalosporins: I. 1st generation Cefphalexin Cefadroxil Cefaclor II. nd generation Cefuroxime axetil Cefprozil III. rd generation - Cefixime - Ceftibuten - Cefpodoxime proxetil - Cefdinir - Cefditoren elative Acitivities Of Oral Cephalosporins (PK/PD based) Generation 1st nd rd Gram+ cocci Gram rod 1 MIC 9 (µg/ml) of oral cephalosporins against Some gram positive species* The Comparative MIC 9 (µg/ml) between Gram Negative For Oral Third and Advanced Generation Cephalosporins Antibiotics Cephalexin <8 Cefuroxime < Cefpodoxime < Cefdinir Cefixime S.pneumoniae PSSP PS - 16-> Staphylococcus aureus MSSA MSA S. pyogens Drug Organism Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Proteus mirabilis Proteus vulgalis Cefditoren Cefdinir Cefixime Cefpodoxime Cefditoren ** <.6 + Morganella morganii * Adapted from Felmingham D. Infectious Diseases Strategy In Clinical To Practice Deliver 1998,;7(Suppl Antibiotic with ): s75-8, **Drug ;6():5-1 5 Kazumitsu Strategy Sano To et Deliver al, Antibiotic with 6

7 Cefdinir mg q 1 hr Cefditoren mg q 1 hr Cefdinir mg q 1 hr % T > MIC % T > MIC 9 PSSP H. Influenzae ole of Oral Cephalosporins In x of infection Community acquired infections Cefpodoxime p. / mg q 1 hr Cefixime mg qd Ceftibuten mg qd 98/ / Novel Otolaryngol Drug Head Neck Surg ;17:S1-S16 8 Clinical Use of oral cephalosporins 1. Skin and Skin Structure Infections ; cellulitis,abscess. UTI (Urinary Tract Infection) Pyelonephritis, Cystitis. Switch Therapy after parenteral cephalosporins Some TIs; sinusitis,otitis media,bronchitis community-acquire pneumonia Need For Novel Antibiotics 1.For resistant pathogen.better PK-PD amoxicillin > pen V / ampicillin azithromycin/ clarithro > erythromycin cefdinir > cephalexin 9 Approaches to minimize cost of treatment is to know the real cost of treatment Total Cost of treatment Direct Cost Drug Drug monitoring Indirect Cost Investigation Hospitalization Cost Intangiable Cost Cost of evisit Lose of / from work Family visit 1 Approaches to minimize cost of treatment eg. with moderate to severe infection Therapy are Switch Therapy or Out patient Antibiotic Therapy or IPD Antibiotic Therapy Oral antibiotic (Switch Therapy) Parenteral antibiotic (OPAT) OPD Day Care Home OPD Therapy 7

8 The single most important step in reducing hospital antibiotic costs is to initiate an outpatient-antibiotic therapy. Conventional belief to the contrary, many infections can be treated orally or parenterally-opd with the same therapeutic effectiveness amirez 199 A Tice BA Cunha 1997 Williams DN, Tice AD, Craig WA: Practice guideline CID 1997,5 To start with oral antibiotic Localized infection eg. some CAP, UUTI Mild-Moderate severeity systemic infection Enteric fever, Ac.pyelonephritis Sequential, Step down from parenteral antibiotic After (During) improvement Good Oral Antibiotics Good Bioavailability vs pathogen (PK-PD based) OD - BID (For Good Compliance) Tolerable Good Oral Antibiotics: Amoxicillin Amoxicillin Clavulanate, ampi-sulbactam Co-trimoxazole Advanced Macrolides (oxithromycin, Azithromycin, Clarithro) Metronidazole Some Cephalosporin 1st Generation: Cefadroxil nd Generation: Cefuroxime rd or advanced generation: Cefdinir, Cefditoren, Cefixime Fluoroquinolones nd - Ofloxacin, Ciprofloxacin. rd - Levofloxacin,Gatiflox th - Moxifloxacin, Gemiflox 5 Doxycycline, Minocycline Clinical Experience with Switch Therapy INFECTIONS Community-acquired pneumonia (CAP) Acute Pyelonephritis, Complicated UTI Skin/Soft-tissue infection Septic arthritis Osteomyelitis Pyogenic liver abscess Melioidosis 6 Switch Therapy/Out Patient Parenteral Therapy General ules of Guidelines Should be applied wisely with respect to Individual variations Type of infections Antimicrobial susceptibility pattern Underlying disease 7 6 y/o female HT, DM, admitted because of septic arthritis of right knee joint, treated with cefazolin gm daily and became afebrile on day 6 th. She was continued on cefazolin for one more week. What should be her choice? 1. continue on IV cefazolin for total of weeks. discharge on.1 oral dicloxacillin 5 mg QID. oral amoxi-clavulanate 1 g TID. oral cephalexin 5 mg QID. oral cefdinir mg BID.5 oral cefditoren mg BID 8 8

9 Switch Therapy For Septic Arthritis I. Parenteral antibiotic 1-1 days: Cloxacillin or Cefazolin (Strep, Stap) or PGS (if culture grew streptococci) II. After D 1 or 1 oral antibiotic: Dicloxacillin Cefadroxil or Cefdinir Penicillin allergic : Clindamycin 9 Outpatient Antibiotic Therapy For Osteomyelitis Pioneer or First treated OPAT Ceftriaxone gm OD Hospital-based OPD programmed (popular in Europe) Doctor office-based programmed (popular in USA) Home-based programmed CID ;:5 5 Outpatient Therapy for Soft Tissue Infection Uncomplicated Cellulitis Mostly Oral Antibiotic or One dose of IM Cefazolin or Clindamycin then Oral antibiotic Underlying Disease Evaluate Patients Complicated severe Hospitalize 51 Streptococci : Staphylococci: Good Oral Antibiotic For Soft Tissue Infection Bioavailability > 7% OD or BID dosing Tolerable Amoxicillin Cefadroxil, Cefdinir, Clindamycin Dicloxacillin Mixed Streptococci + Staphylococci ~ Amoxicillin clavulanate + Anaerobes Clindamycin + oral rd Ceph or Quinolone 5 6 y/o male admitted with diagnosis of AECOPD Community acquired pneumonia Treated with ceftriaxone, with improvement sputum No Commorbidity With Comorbidity or Sever CAP Grew S. pneumoniae, resist to penicillin, sensitive Ceftriaxone. He asked for discharge what would be Oral antibiotic of choice Oral antibiotic rd Ceph 1. Amoxicillin/Advanced macrolide. Amoxy-clavulanate (failed 1). rd. Gen. cephalosporin Improved switch to Oral antibiotic 1st Amoxy-clavulanate+macrolide nd Choice rd-th gen Quinolone 5 5 9

10 Antibiotic In Pyogenic Liver Abscess: Common Pathogen: GNB > 7% Anaerobes 1-% Initial Empiric Antibiotic I. Not Severe Ceftriaxone+Metronidazole or B-lactamase Inhibitor II. Severe sepsis - Add Gentamicin or Metronidazole+Cefazidime (Northeast) Oral Antibiotic In Pyogenic Liver Abscess: 1st: BL-BI nd : rd Ceph* + Metronidazole or Clindamycin 1-1 Days then switch to oral Antibiotic * Any oral rd ceph year old female came in because of dysuria & burning for 1 day. No fever,not sick. Urinalysis : numerous WBC, Appropriate antibiotic should be. 1. Co-trimoxazole. Norfloxacin. Ciprofloxacin. Cefdinir 58 5 yo female,dm,ht.,came in due to fever. BT 7.8 c. 1 yo male c cellulitis lt. foot,no fever. Urinalysis: WBC > /HPF Apropriate antibiotic should be. Appropriate antibiotic should be; 1. IV Cloxacillin 1.Oral cefixime or cefdinir. Oral dicloxacillin. Oral levofloxacin. Ceftazidime. Ceftriaxone. Oral cefdinir.oral cefixime

11 Ceftriaxone for UTI should be given; 1.Once daily.twice daily. Thrice daily Dose of cefdinir for UTI should be mg tid. mg bid. mg od. mg bid. QID

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient 1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime

More information

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis

More information

UTI Dr S Mathijs Department of Pharmacology

UTI Dr S Mathijs Department of Pharmacology UTI Dr S Mathijs Department of Pharmacology Introduction Responsible for > 7 million consultations annually 15% of all antibiotic prescriptions 40% of all hospital acquired infections Significant burden

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic

More information

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Approach to pediatric Antibiotics

Approach to pediatric Antibiotics Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus

More information

Rational management of community acquired infections

Rational management of community acquired infections Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?

More information

Advanced Practice Education Associates. Antibiotics

Advanced Practice Education Associates. Antibiotics Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright

More information

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Antibiotic Stewardship Program (ASP) CHRISTUS SETX Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Discussion Points. Decisions in Selecting Antibiotics

Discussion Points. Decisions in Selecting Antibiotics Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of

More information

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems β-lactams ß-lactams Sub-families Penicillins Cephalosporins Monobactams Carbapenems ß-lactams Mode of action PBPs = Trans/Carboxy/Endo- peptidases PBP binding (Penicillin-Binding Proteins) activation of

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Guidelines for Treatment of Urinary Tract Infections

Guidelines for Treatment of Urinary Tract Infections Guidelines for Treatment of Urinary Tract Infections Overview This document details the Michigan Hospital Medicine Safety (HMS) Consortium preferred antibiotic choices for treatment of uncomplicated and

More information

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases 4 th and 5 th generation cephalosporins Naderi HR Associate professor of Infectious Diseases Classification Forth generation: Cefclidine, cefepime (Maxipime),cefluprenam, cefoselis,cefozopran, cefpirome

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance

Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance Robert C Welliver Sr, MD Hobbs-Recknagel Endowed Chair in Pediatrics Chief, Pediatric infectious Diseases Children s Hospital

More information

Antimicrobial Pharmacodynamics

Antimicrobial Pharmacodynamics Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they

More information

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Cost high. acceptable. worst. best. acceptable. Cost low

Cost high. acceptable. worst. best. acceptable. Cost low Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Pharmacology Week 6 ANTIMICROBIAL AGENTS Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus

Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings

More information

Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs. Disclosure 4/22/17

Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs. Disclosure 4/22/17 Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs Elizabeth O. Hand, Pharm.D., BCPS Pediatric Infectious Disease Pharmacist University Health System Clinical Assistant Professor The

More information

Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007

Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007 Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007 1 Ongoing data from CDC 's Gonococcal Isolate Surveillance Project (GISP), including

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information

Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction

Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs?

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs? Antibiotics & treatment of Acute Bcterial Sinusitis Walid Reda Product Manager Do your antimicrobial options meet your needs? Antimicrobial Effects: What s involved? Effect in Humans: Serum concentration

More information

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital 2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram

More information

Clinical Practice Standard

Clinical Practice Standard Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

Antimicrobial Susceptibility Patterns

Antimicrobial Susceptibility Patterns Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department

More information

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from

More information

number Done by Corrected by Doctor

number Done by Corrected by Doctor number 28 Done by Dina Yaseen Corrected by حسام أبو عوض Doctor مالك الزحلف Cephalosporins -Cephalosporins are β-lactam antibiotics isolated from a strain of Streptomyces. -They are bactericidal and work

More information

Principles of Antibiotics Use & Spectrum of Some

Principles of Antibiotics Use & Spectrum of Some Principles of Antibiotics Use & Spectrum of Some Rabee Adwan. MD Infectious Diseases Consultant (Pediatric and Adult) Head Of ID Unit and IPAC Committee- AL-Makassed Hospital-AlQuds Head of IPAC Committee

More information

Considerations in antimicrobial prescribing Perspective: drug resistance

Considerations in antimicrobial prescribing Perspective: drug resistance Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,

More information

Antimicrobial Update. Vicky Dudas, Pharm.D. Associate Clinical Professor of Pharmacy Director, Antimicrobial Management Program UCSF Medical Center

Antimicrobial Update. Vicky Dudas, Pharm.D. Associate Clinical Professor of Pharmacy Director, Antimicrobial Management Program UCSF Medical Center Antimicrobial Update Vicky Dudas, Pharm.D. Associate Clinical Professor of Pharmacy Director, Antimicrobial Management Program UCSF Medical Center Objectives Discuss treatment of acute bacterial rhinosinusitis

More information

Antimicrobials. Antimicrobials

Antimicrobials. Antimicrobials Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance

More information

Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do?

Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do? Fluoroquinolones in 2007: the Angels, the Devils, and What Should the Clinician Do? David C. Hooper, M.D. Division of Infectious Diseases Infection Control Unit Massachusetts General Hospital Harvard Medical

More information

Antimicrobial Resistance Trends in the Province of British Columbia

Antimicrobial Resistance Trends in the Province of British Columbia 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate Use of Healthcare 2019 COLLECTION

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Search for: Search Search Does levaquin cover anaerobes Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic.

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

Cipro for gram positive cocci in urine

Cipro for gram positive cocci in urine Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar

More information

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital 2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....

More information

New Antibiotics & New Insights into Old Antibiotics

New Antibiotics & New Insights into Old Antibiotics New Antibiotics & New Insights into Old Antibiotics Louisiana Chapter of the American Academy of Pediatrics August 18, 2018 Baton Rouge, Louisiana John Bradley MD Rady Children s Hospital San Diego University

More information

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations

More information

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX.

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX. Antibiotic Stewardship in the Long Term Care Setting Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc. 845.208.3328 LTSRX.com 1 Resistant Bacteria Crisis The Centers for Medicare &

More information

Antimicrobial Therapy

Antimicrobial Therapy Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Disclosure: Dr. Spach has no significant financial interest in any of the

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and

More information

Available online at ISSN No:

Available online at  ISSN No: Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other

More information

CLINICAL USE OF BETA-LACTAMS

CLINICAL USE OF BETA-LACTAMS CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial

More information

Volume 1; Number 7 November 2007

Volume 1; Number 7 November 2007 Volume 1; Number 7 November 2007 CONTENTS Page 1 Page 3 Guidance on the Use of Antibacterial Drugs in Lincolnshire Primary Care: Winter 2007/8 NICE Clinical Guideline 54: Urinary Tract Infection in Children

More information

Antibiotic Updates: Part I

Antibiotic Updates: Part I Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

Rational use of antibiotics

Rational use of antibiotics Rational use of antibiotics Uga Dumpis MD, PhD,, DTM Stradins University Hospital Riga, Latvia ugadumpis@stradini.lv BALTICCARE CONFERENCE, PSKOV, 16-18.03, 18.03, 2006 Why to use antibiotics? Prophylaxis

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate

More information

Antibiotics 1. Lecture 8

Antibiotics 1. Lecture 8 Antibiotics 1 Lecture 8 Overview of antibiotics What am I treating? Viral, bacterial, fungal, mycobacterial, etc. Who am I treating? Host factors: age, genetic factors, co-morbidities (renal and liver

More information